Proxyphylline
- Level
- Commodity
- Parent
- 51161500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51161553This classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula C10H14N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 13G1DMN4P0, chemically known as 3,7-dihydro-7-(2-hydroxypropyl)-1,3-dimethyl-1h-purine-2,6-dione but generally known as proxyphylline, which bears US NIH Compound Identifier 4977. European Medicines Agency schedules Proxyphylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10153MIG. The term PROXYPHYLLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). World Health Organization schedules proxyphylline in its Anatomical Therapeutic Chemical (ATC) Classification. PROXYPHYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule proxyphylline under HS 29395900 and SITC 54145. As of Q4 2014, PROXYPHYLLINE remains the US FDA Preferred Term for this commodity. Proxyphylline bears US NLM identifiers UMLS ID C0072511 and NCI Concept Code C80339. SMILES: CC(CN1C=NC2=C1C(=O)N(C(=O)N2C)C)O.
Same parent
Under 51161500 · 56Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.